Last update 14 Dec 2024
LPM-3770164
Last update 14 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms LPM 3770164, LPM-3770164, LPM3770164 + [1] |
Target |
Mechanism VMAT2 inhibitors(Synaptic vesicular amine transporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
8
Clinical Trials associated with LPM-3770164A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetic Characteristics of Multiple Doses of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
A Randomized, Open-label, Two-period, Double-crossover Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets in Healthy Subjects
评价健康受试者多次空腹口服LPM3770164缓释片安全性、耐受性及药代动力学特征的随机、双盲、安慰剂对照、剂量递增的Ⅰ期临床研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalating phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of multiple oral administrations of LPM3770164 sustained-release tablets on an empty stomach in healthy subjects
100 Clinical Results associated with LPM-3770164
Login to view more data
100 Translational Medicine associated with LPM-3770164
Login to view more data
100 Patents (Medical) associated with LPM-3770164
Login to view more data
100 Deals associated with LPM-3770164
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Tardive Dyskinesia | Phase 2 | CN | 10 Dec 2024 | |
| Huntington Disease | Phase 1 | CN | 25 Feb 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free